Current reversible contraceptive methods: a global perspective
- 1 August 1998
- journal article
- review article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 62 (S1) , S3-S15
- https://doi.org/10.1016/s0020-7292(98)00084-8
Abstract
Since the 1960's there have been important gains in the efforts to make the benefits of family planning accessible to people around the world. However, prevalence of contraceptive use is still low in some areas, especially in sub‐Saharan Africa. Making contraceptives accessible through good quality services should be a goal for reproductive health programs. In the absence of an ideal method of contraception which would suit every individual, there is a variety of contraceptive methods with advantages in some aspects and disadvantages in others from which people should be able to choose according to their particular characteristics and needs. Important aspects to take into consideration include effectiveness, convenience, and safety. In general, the most effective methods are more likely to have some side effects and method‐related complications. However, when weighing the risks and benefits, the most effective methods have greater benefits on the health of women by protecting them better from the health risks of unwanted pregnancies. Most methods also have non‐contraceptive benefits — for instance, combined oral contraceptives (COCs) provide important degrees of protection against endometrial and ovarian cancers, benign breast disease, pelvic inflammatory disease (PID), and ectopic pregnancy. They also reduce menstrual blood loss. Although barrier methods have lower effectiveness against pregnancy, their most important advantage is the protection they can provide against sexually transmitted diseases. The male condom in particular (and probably the female condom) has the special value of providing protection against HIV infection. This paper describes reversible methods of contraception including possible health risks and contraindications. Adequate counseling, however, is essential for people to make an appropriate choice of contraception and to secure safe and effective use of the method.Keywords
This publication has 28 references indexed in Scilit:
- Stroke in Users of Low-Dose Oral ContraceptivesNew England Journal of Medicine, 1996
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesPublished by Elsevier ,1996
- Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic diseaseThe Lancet, 1995
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995
- Safe motherhoodInternational Journal of Gynecology & Obstetrics, 1994
- What we have learned from recent IUD studies: A researcher's perspectiveContraception, 1993
- Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancerContraception, 1992
- The TCu380A, TCu220C, multiload 250 and nova T IUDs at 3, 5 and 7 years of use — Results from three randomized multicentre trialsContraception, 1990
- Combined oral contraceptives and liver cancerInternational Journal of Cancer, 1989